- Conditions
- Osteoporosis
- Interventions
- Risedronate, Parathyroid Hormone
- Drug
- Lead sponsor
- University of California, Davis
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2009
- U.S. locations
- 1
- States / cities
- Sacramento, California
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 25–48
of 24
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Femur Neck Fracture
- Interventions
- Teriparatide, Placebo, Calcium supplementation, Vitamin D supplementation
- Drug · Dietary Supplement
- Lead sponsor
- Eli Lilly and Company
- Industry
- Eligibility
- 50 Years and older
- Enrollment
- 122 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2013
- U.S. locations
- 24
- States / cities
- Phoenix, Arizona • Tucson, Arizona • La Mesa, California + 21 more
- Conditions
- Osteoporosis
- Interventions
- Zoledronic acid, Placebo, Teriparatide
- Drug
- Lead sponsor
- Novartis
- Industry
- Eligibility
- 45 Years to 89 Years · Female only
- Enrollment
- 412 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2009
- U.S. locations
- 18
- States / cities
- Birmingham, Alabama • Beverly Hills, California • La Mesa, California + 15 more
- Conditions
- Implant
- Interventions
- Teriparatide, Placebo
- Drug
- Lead sponsor
- University of Michigan
- Other
- Eligibility
- 30 Years to 85 Years
- Enrollment
- 27 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2011 – 2015
- U.S. locations
- 1
- States / cities
- Ann Arbor, Michigan
- Conditions
- Postmenopausal Osteoporosis, Osteoporosis
- Interventions
- synthetic hPTH 1-34
- Drug
- Lead sponsor
- Massachusetts General Hospital
- Other
- Eligibility
- 46 Years to 85 Years · Female only
- Enrollment
- 80 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2009
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Hypocalcemia
- Interventions
- Teriparatide (Forteo), Calcium, Calcitriol
- Drug
- Lead sponsor
- M.D. Anderson Cancer Center
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 7 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2010
- U.S. locations
- 1
- States / cities
- Houston, Texas
- Conditions
- Postmenopausal Osteoporosis
- Interventions
- Teriparatide, Risedronate, Placebo, Calcium, Vitamin D
- Drug
- Lead sponsor
- Eli Lilly and Company
- Industry
- Eligibility
- 45 Years and older · Female only
- Enrollment
- 1,366 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2016
- U.S. locations
- 30
- States / cities
- Birmingham, Alabama • Concord, California • Fresno, California + 27 more
- Conditions
- Osteoporosis
- Interventions
- Standard Clinical Practice Regimen, Experimental Cyclic Regimen
- Drug
- Lead sponsor
- Health Research, Inc.
- Other
- Eligibility
- 45 Years and older · Female only
- Enrollment
- 60 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2013 – 2018
- U.S. locations
- 1
- States / cities
- West Haverstraw, New York
- Conditions
- Osteoporosis
- Interventions
- Teriparatide, Raloxifene
- Drug
- Lead sponsor
- University of Wisconsin, Madison
- Other
- Eligibility
- 60 Years to 89 Years · Female only
- Enrollment
- 26 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2010 – 2012
- U.S. locations
- 1
- States / cities
- Madison, Wisconsin
- Conditions
- Spinal Cord Injury, Bone Loss, Osteoporosis
- Interventions
- Teriparatide, vibration
- Drug · Device
- Lead sponsor
- Thomas J. Schnitzer
- Other
- Eligibility
- 21 Years and older
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2016
- U.S. locations
- 2
- States / cities
- Chicago, Illinois • Maywood, Illinois
- Conditions
- Osteoporosis, Osteopenia
- Interventions
- Virtual Bone Biopsy, Teriparatide, Zoledronic Acid
- Other · Drug
- Lead sponsor
- University of Pennsylvania
- Other
- Eligibility
- 60 Years and older · Female only
- Enrollment
- 33 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2012
- U.S. locations
- 1
- States / cities
- Philadelphia, Pennsylvania
- Conditions
- Osteoporosis
- Interventions
- Teriparatide (PF708), Teriparatide (Forteo)
- Drug
- Lead sponsor
- Pfenex, Inc
- Industry
- Eligibility
- 30 Years to 85 Years
- Enrollment
- 181 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2018
- U.S. locations
- 26
- States / cities
- Birmingham, Alabama • Mobile, Alabama • Chandler, Arizona + 22 more
- Conditions
- Postmenopausal Osteoporosis
- Interventions
- teriparatide, aldrenodate, raloxifene
- Drug
- Lead sponsor
- Eli Lilly and Company
- Industry
- Eligibility
- 50 Years and older · Female only
- Enrollment
- 200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2007
- U.S. locations
- 10
- States / cities
- Birmingham, Alabama • Huntsville, Alabama • Scottsdale, Arizona + 7 more
- Conditions
- Osteoporosis
- Interventions
- Teriparatide, Alendronate, Calcium, Vitamin D3
- Drug · Dietary Supplement
- Lead sponsor
- Helen Hayes Hospital
- Other
- Eligibility
- 45 Years to 85 Years · Female only
- Enrollment
- 140 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2005 – 2017
- U.S. locations
- 1
- States / cities
- West Haverstraw, New York
- Conditions
- Osteopenia, Osteoporosis
- Interventions
- Teriparatide, Placebo teriparatide
- Drug
- Lead sponsor
- University of California, San Francisco
- Other
- Eligibility
- 45 Years to 70 Years · Female only
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2005
- U.S. locations
- 1
- States / cities
- Bangor, Maine
- Conditions
- Male Osteoporosis
- Interventions
- Teriparatide or human parathyroid hormone (PTH) 1-34, Cinacalcet, placebo tablet, Calcium citrate tablet, Vitamin D3
- Drug · Dietary Supplement
- Lead sponsor
- VA Office of Research and Development
- Federal
- Eligibility
- 60 Years to 85 Years · Male only
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2025
- U.S. locations
- 1
- States / cities
- San Francisco, California
- Conditions
- Osteoporosis, Bone Loss, Spinal Cord Injury
- Interventions
- teriparatide, weight-bearing
- Drug · Other
- Lead sponsor
- Thomas J. Schnitzer
- Other
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 12 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2012
- U.S. locations
- 1
- States / cities
- Chicago, Illinois
- Conditions
- Colles' Fracture
- Interventions
- Teriparatide, placebo
- Drug
- Lead sponsor
- Eli Lilly and Company
- Industry
- Eligibility
- 45 Years to 85 Years · Female only
- Enrollment
- 105 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2007
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Osteoporosis
- Interventions
- teriparatide, Placebo, BA058 20 µg, BA058 40 µg, BA058 80 µg
- Drug
- Lead sponsor
- Radius Health, Inc.
- Industry
- Eligibility
- 55 Years to 85 Years · Female only
- Enrollment
- 222 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2009
- U.S. locations
- 1
- States / cities
- Cambridge, Massachusetts
- Conditions
- Postmenopausal Osteoporosis
- Interventions
- Teriparatide, Denosumab
- Drug
- Lead sponsor
- Massachusetts General Hospital
- Other
- Eligibility
- 45 Years and older · Female only
- Enrollment
- 37 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019 – 2022
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Hypoparathyroidism Post-surgical
- Interventions
- Teriparatide
- Drug
- Lead sponsor
- Mayo Clinic
- Other
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 5 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2013
- U.S. locations
- 1
- States / cities
- Rochester, Minnesota
- Conditions
- Osteoporosis, Postmenopausal
- Interventions
- teriparatide, raloxifene HCl, placebo
- Drug
- Lead sponsor
- Eli Lilly and Company
- Industry
- Eligibility
- 55 Years to 80 Years · Female only
- Enrollment
- 330 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2001 – 2005
- U.S. locations
- 2
- States / cities
- Maywood, Illinois • Portland, Oregon
- Conditions
- Osteoporosis
- Interventions
- zoledronic acid
- Drug
- Lead sponsor
- The Cleveland Clinic
- Other
- Eligibility
- Up to 85 Years · Female only
- Enrollment
- 35 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2008
- U.S. locations
- 1
- States / cities
- Cleveland, Ohio
- Conditions
- Osteoporosis, Postmenopausal Osteoporosis
- Interventions
- Placebo, BA058 80 mcg, teriparatide
- Drug
- Lead sponsor
- Radius Health, Inc.
- Industry
- Eligibility
- 50 Years to 85 Years · Female only
- Enrollment
- 2,463 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2014
- U.S. locations
- 5
- States / cities
- Lakewood, Colorado • Miami, Florida • North Miami, Florida + 2 more